Paul Tudor Jones Tudor Investment Corp
Paul Tudor Jones is the founder of Tudor Investment Corporation and a pioneering macro trader. He rose to prominence after navigating the 1987 market crash successfully and has since built a multi-strategy firm spanning global markets. Jones is widely associated with discretionary macro trading, risk management discipline, and high-profile philanthropic efforts in education and the environment.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$46.8M |
| 2 |
Zimmer Biomet
ZBH
|
+$40.5M |
| 3 |
IHS
IHS INC CL-A COM STK
IHS
|
+$22.8M |
| 4 |
Fidelity National Information Services
FIS
|
+$21.7M |
| 5 |
HOLX
Hologic
HOLX
|
+$16.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$116M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$99M |
| 3 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$25.2M |
| 4 |
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
|
+$22.2M |
| 5 |
Paychex
PAYX
|
+$20.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.31% |
| 2 | Industrials | 9.79% |
| 3 | Technology | 8.51% |
| 4 | Consumer Discretionary | 7.95% |
| 5 | Financials | 4.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1026
Amphenol
APH
$188B
| $290K | 0.01% |
+23,200
| New | +$291K |
|
|
NYRT
1027
DELISTED
New York REIT, Inc.
NYRT
| $290K | 0.01% |
+2,818
| New | +$297K |
|
|
SCLN
1028
DELISTED
Sciclone Pharmaceuticals Inc
SCLN
| $290K | 0.01% |
+42,053
| New | +$252K |
|
1029
Middleby
MIDD
$5.27B
| $289K | 0.01% |
+3,278
| New | +$272K |
|
|
SFS
1030
DELISTED
Smart & Final Stores, Inc.
SFS
| $289K | 0.01% |
+20,000
| New | +$269K |
|
1031
Hormel Foods
HRL
$13.3B
| $288K | 0.01% |
+11,200
| New | +$273K |
|
1032
Navient
NAVI
$893M
| $287K | 0.01% |
+16,210
| New | +$285K |
|
1033
Qualys
QLYS
$6.2B
| $287K | 0.01% |
+10,789
| New | +$272K |
|
1034
SLR Investment Corp
SLRC
$688M
| $286K | 0.01% |
+15,317
| New | +$308K |
|
1035
IBM
IBM
$218B
| $285K | 0.01% |
1,569
-9,081
| -85% | -$1.65M |
|
1036
Virtus Investment Partners
VRTS
$1.13B
| $285K | 0.01% |
+1,639
| New | +$333K |
|
|
TUMI
1037
DELISTED
TUMI HLDGS INC COM
TUMI
| $285K | 0.01% |
+14,000
| New | +$297K |
|
1038
Universal Display
OLED
$3.87B
| $284K | 0.01% |
+8,698
| New | +$287K |
|
|
SVC
1039
Service Properties Trust
SVC
$1.05B
| $284K | 0.01% |
2,127
+601
| +39% | +$87K |
|
|
NE
1040
DELISTED
Noble Corporation
NE
| $284K | 0.01% |
+12,800
| New | +$345K |
|
|
CYNO
1041
DELISTED
Cynosure, Inc. Class A
CYNO
| $283K | 0.01% |
13,472
-1,194
| -8% | -$26.3K |
|
|
DRIV
1042
DELISTED
DIGITAL RIVER INC.
DRIV
| $282K | 0.01% |
19,400
-20,700
| -52% | -$311K |
|
|
PCTI
1043
DELISTED
PCTEL, Inc. Common Stock
PCTI
| $281K | 0.01% |
+37,065
| New | +$288K |
|
1044
Chord Energy
CHRD
$8.02B
| $280K | 0.01% |
+6,700
| New | +$333K |
|
1045
Douglas Emmett
DEI
$2.01B
| $280K | 0.01% |
+10,919
| New | +$307K |
|
1046
PDF Solutions
PDFS
$1.86B
| $280K | 0.01% |
+22,212
| New | +$441K |
|
|
LQ
1047
DELISTED
La Quinta Holdings Inc.
LQ
| $280K | 0.01% |
+14,770
| New | +$286K |
|
|
OUTR
1048
DELISTED
OUTERWALL INC
OUTR
| $279K | 0.01% |
4,979
-6,921
| -58% | -$401K |
|
1049
Credit Acceptance
CACC
$6.27B
| $277K | 0.01% |
2,196
-2,597
| -54% | -$318K |
|
1050
Keurig Dr Pepper
KDP
$44.3B
| $277K | 0.01% |
4,300
+400
| +10% | +$24.4K |
|
Similar funds
Paul Tudor Jones's Q3 2014 Portfolio in Review
As of Q3 2014, Paul Tudor Jones held 1,629 positions worth $2.77B, up 6.2% from $2.61B the previous quarter. Its ten largest holdings account for 44% of the portfolio.
Paul Tudor Jones deployed $200M of net new capital in Q3 2014, opening 486 new positions and adding to 513 existing holdings. Its largest new stake was Alibaba: 520,750 shares worth $46.3M.
By sector, the portfolio is most concentrated in Healthcare at 12% of assets, up from 11% a quarter earlier, followed by Industrials and Technology.
On the sell side, the largest reduction was Apple, an estimated $116M trimmed.
- Paul Tudor Jones's largest Q3 2014 buy was Alibaba: 520,750 shares worth $46.3M.
- Paul Tudor Jones added most to Zimmer Biomet in Q3 2014, an estimated $40.5M increase.
- Paul Tudor Jones's biggest Q3 2014 reduction was Apple, cutting an estimated $116M.
- Paul Tudor Jones fully exited iShares MSCI Emerging Markets ETF in Q3 2014, selling an estimated $99M.
- Paul Tudor Jones's ten largest holdings make up 44% of its $2.77B portfolio in Q3 2014.
- Paul Tudor Jones opened 486 new positions and closed 300 in Q3 2014.
- Paul Tudor Jones's portfolio value rose 6.2% quarter-over-quarter to $2.77B.
Based on Tudor Investment Corp's 13F filing for Q3 2014, filed 14 Nov 2014.